H Pouleur

Author PubWeight™ 54.01‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 1992 7.22
2 Effects of a cardioselective beta 1 partial agonist (corwin) on left ventricular function and myocardial metabolism in patients with previous myocardial infarction. Am J Cardiol 1983 2.10
3 Baseline quality of life as a predictor of mortality and hospitalization in 5,025 patients with congestive heart failure. SOLVD Investigations. Studies of Left Ventricular Dysfunction Investigators. Am J Cardiol 1996 1.64
4 Angiographic evaluation of vasomotor properties of internal mammary arteries before and after coronary artery bypass grafting in men. Am J Cardiol 1990 1.39
5 Early detection of doxorubicin cardiotoxicity: interest of Doppler echocardiographic analysis of left ventricular filling dynamics. Am Heart J 1989 1.25
6 Improvement of global and regional left ventricular function in patients with previous myocardial infarction by a new beta 1 adrenoceptor partial agonist, ICI 118,587. Eur Heart J 1982 1.16
7 Global ischaemia induces a biphasic response of the mitochondrial respiratory chain. Anoxic pre-perfusion protects against ischaemic damage. Biochem J 1992 1.14
8 Effects of ranolazine on left ventricular regional diastolic function in patients with ischemic heart disease. Cardiovasc Drugs Ther 1994 1.13
9 Impaired early left ventricular relaxation in coronary artery disease: effects of intracornary nifedipine. Circulation 1980 1.12
10 Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure. J Card Fail 2000 1.04
11 Force-velocity-length relations in hypertrophic cardiomyopathy: evidence of normal or depressed myocardial contractility. Am J Cardiol 1983 0.99
12 Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem. J Cardiovasc Pharmacol 1992 0.96
13 Effects of coronary occlusion on early ventricular diastolic events in conscious dogs. Am J Physiol 1979 0.96
14 Effects of nitroprusside on venous return and central blood volume in the absence and presence of acute heart failure. Circulation 1980 0.94
15 Assessment of regional left ventricular relaxation in patients with coronary artery disease: importance of geometric factors and changes in wall thickness. Circulation 1984 0.89
16 Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohormonal activation and effects of ibopamine therapy during long-term therapy with angiotensin-converting enzyme inhibitor. Am J Cardiol 1994 0.88
17 Effects of D-nebivolol and L-nebivolol on left ventricular systolic and diastolic function: comparison with D-L-nebivolol and atenolol. J Cardiovasc Pharmacol 1993 0.87
18 Effects of intravenous epinine administration on left ventricular systolic performance, coronary hemodynamics, and circulating catecholamines in patients with heart failure. J Cardiovasc Pharmacol 1992 0.86
19 Cardiovascular effects of AR-L115 BS in conscious dogs with and without chronic congestive heart failure. J Cardiovasc Pharmacol 1982 0.86
20 Effects of nicardipine and nisoldipine on myocardial metabolism, coronary blood flow and oxygen supply in angina pectoris. Am J Cardiol 1984 0.86
21 Changes in myocardial metabolism during therapy in patients with chronic stable angina: a comparison of long-term dosing with propranolol and nicardipine. Circulation 1986 0.84
22 Effects of asynchrony on myocardial relaxation at rest and during exercise in conscious dogs. Am J Physiol 1988 0.84
23 Myocardial protection by intracoronary nicardipine administration during percutaneous transluminal coronary angioplasty. Am J Cardiol 1987 0.83
24 Changes in coronary blood flow and myocardial metabolism during aortic balloon valvuloplasty. Am J Cardiol 1988 0.82
25 Effects of alterations in aortic input impedance on the force-velocity-length relationship in the intact canine heart. Circ Res 1979 0.82
26 Inotropic drugs of the future. Eur J Clin Invest 1982 0.82
27 [Role of adrenergic beta receptor partial agonists in left ventricular failure of ischemic origin. Value of xamoterol (ICI 118,587, Corwin)]. Ann Med Interne (Paris) 1985 0.81
28 Effects of dobutamine and sulmazol (AR-L115 BS) on myocardial metabolism and coronary, femoral, and renal blood flows: a comparative study in normal dogs and in dogs with chronic volume overload. J Cardiovasc Pharmacol 1983 0.81
29 Comparisons of the inotropic effects of the beta 1-adrenoceptor partial agonists SL 75.177.10 and ICI 118,587 with digoxin on the intact canine heart. J Cardiovasc Pharmacol 1984 0.81
30 Hemodynamic and cardiac effects of nicardipine in patients with coronary artery disease. J Cardiovasc Pharmacol 1984 0.81
31 [The value of xamoterol in moderate ischemic cardiac insufficiency]. Ann Cardiol Angeiol (Paris) 1984 0.81
32 Effects of nicardipine or nifedipine added to propranolol in patients with coronary artery disease. Postgrad Med J 1984 0.81
33 Regional remodeling and nonuniform changes in diastolic function in patients with left ventricular dysfunction: modification by long-term enalapril treatment. The SOLVD Investigators. J Am Coll Cardiol 1993 0.80
34 Medium-term effects of beta-blockade on left ventricular mechanics: a double-blind, placebo-controlled comparison of nebivolol and atenolol in patients with ischemic left ventricular dysfunction. J Card Fail 1996 0.80
35 Changes in plasma renin activity and haemodynamics during vasodilator therapy in conscious dogs with myocardial infarction or chronic volume overload. Eur J Clin Invest 1983 0.80
36 Impaired regional diastolic distensibility in coronary artery disease: relations with dynamic left ventricular compliance. Am Heart J 1986 0.80
37 Costs and effects of enalapril therapy in patients with symptomatic heart failure: an economic analysis of the Studies of Left Ventricular Dysfunction (SOLVD) Treatment Trial. J Card Fail 1995 0.80
38 Diastolic viscous properties of the intact canine left ventricle. Circ Res 1979 0.80
39 Role of endogenous endothelin-1 in experimental renal hypertension in dogs. Circulation 1995 0.79
40 Wall motion asynchrony is a major determinant of impaired left ventricular filling in patients with healed myocardial infarction. Am J Cardiol 1993 0.79
41 Effects of long-term combined dosing with nicardipine and propranolol on coronary hemodynamics, myocardial metabolism, and exercise tolerance in patients with angina pectoris: comparison with monotherapy. Am Heart J 1988 0.79
42 Diastolic properties in canine hypertensive left ventricular hypertrophy: effects of angiotensin converting enzyme inhibition and angiotensin II type-1 receptor blockade. Cardiovasc Res 1997 0.79
43 Relationship between changes in left ventricular inotropic state and relaxation in normal subjects and in patients with coronary artery disease. Circulation 1981 0.78
44 Effects of nicardipine on coronary blood flow, left ventricular inotropic state and myocardial metabolism in patients with angina pectoris. Br J Clin Pharmacol 1985 0.78
45 Cardiovascular and endocrine effects of endothelin-1 at pathophysiological and pharmacological plasma concentrations in conscious dogs. Circulation 1991 0.78
46 Relationship between positive inotropic responses and plasma concentrations of xamoterol in middle-aged and elderly patients. Br J Clin Pharmacol 1990 0.78
47 Free-wall shortening and relaxation during ejection in the canine right ventricle. Am J Physiol 1980 0.77
48 Circulatory effects of deep inspirations, blocked expirations and positive pressure inflations at equal transpulmonary pressures in conscious dogs. J Physiol 1974 0.77
49 Dose-related efficacy of irbesartan for hypertension: an integrated analysis. Hypertension 1998 0.77
50 Alterations in myocardial metabolism and function at rest in stable angina pectoris: relations with the amount of exercise-induced thallium-201 perfusion defect. Cathet Cardiovasc Diagn 1986 0.77
51 Assessment of left ventricular contractility from late systolic stress-volume relations. Circulation 1982 0.77
52 Echocardiographic assessment of lack of beta 1-receptor down-regulation during prolonged therapy with xamoterol. Eur Heart J 1990 0.77
53 Effects of endothelin-1 at pathophysiologic concentrations on coronary perfusion and mechanical function of normal and postischemic myocardium. J Cardiovasc Pharmacol 1994 0.76
54 Assessment of thallium-201 redistribution versus glucose uptake as predictors of viability after coronary occlusion and reperfusion. Circulation 1988 0.75
55 Low-dose endothelin-1 potentiates volume-induced secretion of atrial natriuretic factor. Am J Physiol 1992 0.75
56 Effects of nisoldipine therapy on myocardial perfusion and neuro-hormonal status in patients with severe ischaemic left ventricular dysfunction. Eur Heart J 1994 0.75
57 Contrasting effects of single doses of pindolol and xamoterol on left ventricular diastolic function. Br J Clin Pharmacol 1989 0.75
58 Early changes in sodium and water balances in patients with acute myocardial infarction: relationship to haemodynamics and creatine kinase. Eur J Clin Invest 1984 0.75
59 Effects of intracoronary infusion of nicardipine during silent ischaemia on myocardial metabolism and function. Eur Heart J 1988 0.75
60 Progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators. The Studies of Left Ventricular Dysfunction. Ann Ital Med Int 1993 0.75
61 Effects of enhanced afterload and contractile state on the left ventricular late systolic wall stress-dimension relation. Am J Cardiol 1984 0.75
62 [Kussmaul's paradoxical pulse. Etiopathogenic aspects]. Arch Mal Coeur Vaiss 1981 0.75
63 Pulmonary blood volume and haemodynamic changes during steady lung inflations in dogs. Acta Anaesthesiol Scand 1973 0.75
64 [Effects of a partial agonist of beta 1 adrenergic receptors (ICI 118,587) on left ventricular performance and metabolism in coronary disease]. Arch Mal Coeur Vaiss 1984 0.75
65 Increased sensitivity of left ventricular relaxation to inotropic interventions in patients with coronary artery disease: comparison with normal subjects, mitral stenosis and asymmetric septal hypertrophy. Eur Heart J 1980 0.75
66 Nifedipine in hypertrophic cardiomyopathy. Circulation 1982 0.75
67 A model of the cardiovascular regulation as a diagnostic tool in acute myocardial infarction. Acta Cardiol Suppl 1981 0.75
68 Iterative cardiac catheterization: usefulness and limitations in follow-up studies. Adv Cardiol 1986 0.75
69 Hemodynamic and cardiac effects of the selective T-type and L-type calcium channel blocking agent mibefradil in patients with varying degrees of left ventricular systolic dysfunction. J Am Coll Cardiol 1996 0.75
70 Left ventricular wall stress and aortic input impedance. Fed Proc 1980 0.75
71 Ejection fraction response to upright exercise in hypertension: relation to loading conditions and to contractility. Int J Cardiol 1987 0.75
72 Cardiac function early after left ventricular aneurysmectomy correlated to preoperative data and late postoperative course. Thorac Cardiovasc Surg 1979 0.75
73 Dose-related hemodynamic and electrocardiographic effects of the calcium promoter BAY y 5959 in the presence or absence of congestive heart failure. J Am Coll Cardiol 1997 0.75
74 Changes in control of renin release in congestive heart failure in dogs: response to acute and chronic vasodilator therapy. Clin Exp Hypertens A 1982 0.75
75 [Interest of indices of left ventricular function in assessment of coronary heart disease (author's transl)]. Ann Cardiol Angeiol (Paris) 1980 0.75
76 Contractile state is the major determinant of functional outcome in patients with left ventricular dysfunction treated with enalapril. Eur Heart J 1995 0.75
77 Load-sensitive diastolic relaxation in hypertrophied left ventricles. Am J Physiol 1998 0.75
78 The receptor concept revisited. Acta Clin Belg 1985 0.75
79 Effects of nicardipine on regional diastolic left ventricular function in patients with angina pectoris. Circulation 1990 0.75
80 Illustration of the effects of long-term xamoterol therapy on the time course of left ventricular pressure. Eur Heart J 1990 0.75
81 [LVFUN: a program for the analysis and storage of ventriculographic and hemodynamic data]. Ann Radiol (Paris) 1983 0.75
82 Cardiac involvement in Ribbing's disease. Eur Heart J 1994 0.75
83 Significance of pulmonary input impedance in right ventricular performance. Cardiovasc Res 1978 0.75
84 Endothelin-1 exacerbates diastolic stunning in conscious dogs. Am J Physiol 1993 0.75
85 Effects of benazeprilat on left ventricular systolic and diastolic function and neurohumoral status in patients with ischemic heart disease. Circulation 1990 0.75
86 The effects of tolazoline, nitroprusside, nitroglycerin, isoproterenol and hydralazine on pulmonary circulation early after heart valve replacement. Thorac Cardiovasc Surg 1982 0.75
87 Effects of atriopeptin III on renal function, regional blood flows and left ventricular function in conscious dogs in presence or absence of hypovolaemia. Eur J Clin Invest 1986 0.75
88 An evaluation of the safety of the beta-modulator cicloprolol in chronic heart failure. Clin Cardiol 1992 0.75
89 [Limitations of the clinical assessment of myocardial contractility]. Schweiz Med Wochenschr 1985 0.75
90 Safety of concomitant potassium-sparing diuretics in angiotensin-converting enzyme inhibitor therapy in severe congestive heart failure. Xamoterol in Severe Heart Failure Study Group. J Cardiovasc Pharmacol 1994 0.75
91 Cardiac function early after repair of tetralogy of Fallot. J Thorac Cardiovasc Surg 1975 0.75
92 Alterations in endocardial vascular resistance after reperfusion in a low flow, high demand model of ischemia: effects of dipyridamole and WEB-2086, a platelet-activating factor antagonist. J Am Coll Cardiol 1990 0.75
93 Effects of disopyramide and aprindine on arrhythmias after acute myocardial infarction. Eur J Cardiol 1977 0.75
94 Cardiac and hemodynamic effects of intravenous dofetilide in patients with heart failure. Am J Cardiol 2001 0.75
95 Effects of chronic volume overload on left ventricular response to tachycardia. Am J Physiol 1983 0.75
96 Effects of alinidine on metabolic response to high-demand myocardial ischemia. J Cardiovasc Pharmacol 1989 0.75
97 [Diastolic dysfunction in heart failure. Further studies on diagnosis and therapy are necessary]. Lakartidningen 1995 0.75
98 Comparison of tension-velocity-length-relations during right and left ventricular ejections [proceedings]. Arch Int Physiol Biochim 1979 0.75
99 [Results of surgery to repair Fallot's tetralogy. With reference to 91 patients operated on (author's transl)]. Ann Chir Thorac Cardiovasc 1975 0.75
100 Proceedings: [Importance of pulmonary vascular resistance and compliance factors on right ventricular performance]. Arch Int Physiol Biochim 1975 0.75
101 Preload, afterload, volume loading, pressure loading. Circulation 1977 0.75
102 Assessment of left ventricular relaxation in patients with valvular regurgitation. Am J Cardiol 1982 0.75
103 Comparative study of in vitro hydrodynamic behaviour between three differently designed fascia lata valves and the Starr-Edwards prosthesis in aortic position. Eur Surg Res 1973 0.75